S
Simon Zhornitsky
Researcher at Yale University
Publications - 78
Citations - 1613
Simon Zhornitsky is an academic researcher from Yale University. The author has contributed to research in topics: Cognition & Craving. The author has an hindex of 18, co-authored 68 publications receiving 1166 citations. Previous affiliations of Simon Zhornitsky include Foothills Medical Centre & Université de Montréal.
Papers
More filters
Journal ArticleDOI
Thalamic Cortical Error–Related Responses in Adult Social Drinkers: Sex Differences and Problem Alcohol Use
Jaime S. Ide,Simon Zhornitsky,Herta H. Chao,Sheng Zhang,Sien Hu,Wuyi Wang,John H. Krystal,Chiang-Shan R. Li +7 more
TL;DR: The results suggest sex differences in error-related activations with heavier drinking associated with reduced error activations in women but not in men may reflect higher physiological arousal in response to errors and greater vulnerability of saliency-related arousal response to problem drinking in female as compared with male social drinkers.
Journal ArticleDOI
Heart Rate Variability, Cue-Evoked Ventromedial Prefrontal Cortical Response, and Problem Alcohol Use in Adult Drinkers.
TL;DR: Findings substantiate the neural correlates of the presumably parasympathetic response during alcohol cue exposure and the interrelationship among ventromedial prefrontal cortex activity, autonomic response, and problem alcohol use.
Journal ArticleDOI
Acute effects of partial CB1 receptor agonists on cognition - A meta-analysis of human studies.
Simon Zhornitsky,Julie Pelletier,Roxane Assaf,Sarah Giroux,Chiang-Shan R. Li,Stéphane Potvin +5 more
TL;DR: Verbal learning/memory and working memory are most prominently affected by acute administration of partial CB1 receptor agonists, consistent with the residual cognitive effects that have been documented among chronic cannabis users.
Journal ArticleDOI
Switching from conventional antipsychotics to ziprasidone: A randomized, open-label comparison of regimen strategies
TL;DR: There was some evidence that the slow-taper strategy was associated with greater reductions in BPRS total scores early in the study compared to the other two strategies, however, these differences did not remain significant at endpoint, suggesting that there was no overall difference between the strategies.
Journal ArticleDOI
Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine.
Simon Zhornitsky,Emmanuel Stip,Joelle Desfossés,Tania Pampoulova,Élie Rizkallah,Pierre-Paul Rompré,Lahcen Ait Bentaleb,Olivier Lipp,Jean-Pierre Chiasson,Alain Gendron,Stéphane Potvin +10 more
TL;DR: The results provide evidence for increased vulnerability to the adverse effects of alcohol and drugs in schizophrenia patients and suggest that substance abuse/withdrawal may mimic some symptoms of schizophrenia.